Evaluation of clinical phenotype, survival, and circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Bitting, Rhonda Lynn
Healy, Patrick
Halabi, Susan
George, Daniel J.
Ko, Jung Hyun
Armstrong, Andrew J.
机构：
[1] Duke Canc Inst, Durham, NC USA
[2] Duke Univ Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5031
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Danila, D. C.
    Leversha, M. A.
    Gonzalez-Espinoza, R.
    Anand, A.
    Gu, B.
    Gignac, G. A.
    Larson, S.
    Heller, G.
    Fleisher, M.
    Scher, H. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide
    Baciarello, Giulia
    Sternberg, Cora N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 106 : 14 - 24
  • [43] BURDEN OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) IN TURKEY
    Erdal, E.
    Malhan, S.
    Oksuz, E.
    Benekli, M.
    Cag, C.
    Dane, F.
    Kabasakal, L.
    Kucuk, O.
    Sozen, T. S.
    Sar, C.
    Kahveci, B.
    VALUE IN HEALTH, 2016, 19 (07) : A725 - A726
  • [44] Testosterone levels in metastatic castration-resistant prostate cancer (mCRPC).
    von Klot, Christoph A. J.
    Boeker, Alena
    Herrmann, Thomas R. W.
    Kramer, Mario W.
    Kuczyk, Markus A.
    Merseburger, Axel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [45] Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer
    Scher, H. I.
    Armstrong, A. J.
    Schonhoft, J. D.
    Gill, A.
    Zhao, J. L.
    Barnett, E.
    Carbone, E.
    Lu, J.
    Antonarakis, E. S.
    Luo, J.
    Tagawa, S.
    dos Anjos, C. H.
    Yang, Q.
    George, D.
    Szmulewitz, R.
    Danila, D. C.
    Wenstrup, R.
    Gonen, M.
    Halabi, S.
    EUROPEAN JOURNAL OF CANCER, 2021, 150 : 83 - 94
  • [46] MOLECULAR PROFILING OF PERIPHERAL BLOOD IS ASSOCIATED WITH CIRCULATING TUMOR CELLS (CTCS) CONTENT AND SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Gaba Garcia, L.
    Marin-Aguilera, M.
    Lozano, J. J.
    Tagliapietra, A.
    Ortega, V.
    Gascon, P.
    Mellado, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 300 - 300
  • [47] External validation of a prognostic model for overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC).
    Halabi, Susan
    Dutta, Sandipan
    Araujo, John C.
    Logothetis, Christopher
    Sternberg, Cora N.
    Armstrong, Andrew J.
    Carducci, Michael Anthony
    Chi, Kim N.
    De Bono, Johann S.
    Petrylak, Daniel Peter
    Fizazi, Karim
    Higano, Celestia S.
    Small, Eric Jay
    Kelly, William Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Baseline and post-treatment circulating tumor cell (CTC) counts with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (TRT) in men with metastatic castration-resistant prostate cancer (mCRPC).
    Sun, Michael
    Lebenthal, Justin M.
    Nauseef, Jones T.
    Niaz, Muhammad Junaid
    Guervil, Sabrina
    Fernandez, Escarleth
    Patel, Amie
    Tan, Angela
    Vlachostergios, Panagiotis J.
    Osborne, Joseph
    Molina, Ana M.
    Sternberg, Cora N.
    Nanus, David M.
    Bander, Neil Harrison
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [49] Circulating tumor cell (CTC) counts and CTC telomerase activity (TA) as prognotic markers of overall survival (OS) in SWOG S0421: Docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer (mCRPC).
    Goldkorn, Amir
    Vogelzang, Nicholas J.
    Fink, Louis M.
    Ely, Benjamin
    Quinn, David I.
    Tangen, Catherine M.
    Tai, Yu-Chong
    Twardowski, Przemyslaw
    Van Veldhuizen, Peter J.
    Agarwal, Neeraj
    Carducci, Michael Anthony
    Monk, J. P.
    Garzotto, Mark
    Mack, Philip C.
    Lara, Primo
    Higano, Celestia S.
    Hussain, Maha
    Cote, Richard J.
    Thompson, Ian Murchie
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30)
  • [50] Validation of correlation of RECIST changes with survival in metastatic castration-resistant prostate cancer (mCRPC).
    Pond, Gregory Russell
    Templeton, Arnoud J.
    Petrylak, Daniel Peter
    Fandi, Abderrahim
    Tombal, Bertrand F.
    Rosenthal, Mark
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345